Renalytix plc financial data

Symbol
RNLXY, RENXF, RNLXD on OTC
Location
London
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2024 - 19 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 45% % -74%
Debt-to-equity -186% % -168%
Return On Equity 293% %
Return On Assets -342% % -135%
Operating Margin -1055% % 23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 165,925,513 shares 75%
Common Stock, Shares, Outstanding 165,925,513 shares 77%
Common Stock, Value, Issued $515,000 USD 78%
Weighted Average Number of Shares Outstanding, Basic 105,697,401 shares 12%
Weighted Average Number of Shares Outstanding, Diluted 105,697,401 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,352,000 USD -19%
Cost of Revenue $2,053,000 USD -18%
General and Administrative Expense $16,963,000 USD -36%
Operating Income (Loss) $24,812,000 USD 37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $28,024,000 USD 36%
Income Tax Expense (Benefit) $6,000 USD 500%
Net Income (Loss) Attributable to Parent $28,030,000 USD 36%
Earnings Per Share, Basic 0 USD/shares 52%
Earnings Per Share, Diluted 0 USD/shares 52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $909,000 USD -93%
Accounts Receivable, after Allowance for Credit Loss, Current $902,000 USD -11%
Assets, Current $2,879,000 USD -83%
Property, Plant and Equipment, Net $202,000 USD -79%
Operating Lease, Right-of-Use Asset $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $869,000 USD -11%
Assets $4,794,000 USD -75%
Employee-related Liabilities, Current $259,000 USD -89%
Accrued Liabilities, Current $2,162,000 USD -53%
Liabilities, Current $12,013,000 USD -21%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $16,113,000 USD -23%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,029,000 USD -52%
Retained Earnings (Accumulated Deficit) $216,510,000 USD -15%
Stockholders' Equity Attributable to Parent $11,319,000 USD -659%
Liabilities and Equity $4,794,000 USD -75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,836,000 USD 60%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $23,000 USD
Common Stock, Shares Authorized 173,841,695 shares 70%
Common Stock, Shares, Issued 165,925,513 shares 77%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,771,000 USD 65%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $55,438,000 USD 22%
Operating Lease, Liability $11,500 USD -92%
Depreciation $110,000 USD -63%
Lessee, Operating Lease, Liability, to be Paid $11,600 USD -92%
Property, Plant and Equipment, Gross $515,000 USD -73%
Operating Lease, Liability, Current $11,000 USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year Two $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,600 USD -92%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $100 USD -99%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $45,962,000 USD 22%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $44,000 USD -66%
Amortization of Intangible Assets $50,000 USD 0%
Depreciation, Depletion and Amortization $60,000 USD -53%
Deferred Tax Assets, Net of Valuation Allowance $82,000 USD -82%
Share-based Payment Arrangement, Expense $1,440,000 USD -47%